SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
AVTR

Avantor, Inc. (New York Stock Exchange:AVTR)

US · Delayed Price · Currency is USD
Healthcare · Medical - Instruments & Supplies
$14.84-$0.28 (-1.85%)
 
Market cap
$10.1B
Insider Score
Health Score
Analyst consensus
Listed since
May 17, 2019
Market Cap$10.06B+28.8%
Revenue (ttm)$6.64B+0.9%
Net Income$337.20M+510.2%
EPS$0.50+515.3%
Shares Out677.62M
PE Ratio29.61
Forward PE16.70
Dividendn/a
Ex-Dividend Daten/a
Volume12,253,271
Open$15.11
Previous Close$15.12
Day's Range$14.79 - $15.50
52-Week Range$7.26 - $17.45
Beta0.95
AnalystsHold
Price Target$14.55(-1.95%)
Earnings DateFeb 10, 2027

About AVTR

Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. Operating across the Americas, Europe, Asia, the Middle East, and Africa, Avantor caters to a wide array of industries, including biopharmaceuticals, healthcare, educational institutions, government bodies, advanced technology firms, and applied materials enterprises. The company's extensive product portfolio features essential materials and consumables, such as high-purity chemicals and reagents, laboratory supplies, custom-formulated silicone materials, tailored excipients, single-use assemblies, process chromatography resins and columns, analytical sample preparation kits, educational and microbiology products, clinical trial kits, peristaltic pumps, and various fluid handling tips. Beyond consumables, Avantor also supplies advanced equipment and instrumentation. This range includes filtration and virus inactivation systems, incubators, analytical devices, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. Complementing its product offerings, Avantor delivers a suite of crucial services. These encompass on-site laboratory and production support, clinical services, equipment maintenance, comprehensive procurement and sourcing solutions, and specialized biopharmaceutical material scale-up and development expertise.

Address
Radnor Corporate Center, Radnor, PA, 19087, US
Market Cap
10.06 billion
Employees
13,500
Industrial Classification
Medical - Instruments & Supplies

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$1.29M

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Analyst consensus

Hold
1 Buy5 Hold1 SellAvg target $12.75 (-14.1%)

7 firms rating AVTR in the last 3 months, one vote each. Issuer-paid research is not counted.

Financial Health Score
Sound
From AVTR’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-1.85%
5 Days
-4.01%
1 Month
-14.02%
6 Months
+88.56%
1 Year
+28.82%

$AVTR stock is featured in our Congress Trading, and Insider Trades datasets.

→ All Stock Lists

Congress Trading

Recent trades of AVTR by members of U.S. Congress

Gilbert Ray CisnerosHouse / DSale$1.00K – $15.00KAug 13, 2025
Gilbert CisnerosHouse / DSale$1.00K – $15.00KAug 13, 2025
Gilbert Ray CisnerosHouse / DSale$1.00K – $15.00KAug 12, 2025
Gilbert CisnerosHouse / DSale$1.00K – $15.00KAug 12, 2025
Gilbert Ray CisnerosHouse / DSale$1.00K – $15.00KAug 11, 2025
Gilbert Ray CisnerosHouse / DSale$1.00K – $15.00KJul 23, 2025
Gilbert CisnerosHouse / DSale$1.00K – $15.00KJul 23, 2025
Lisa C. McClainHouse / RSale$1.00K – $15.00KJun 17, 2025

Recently reported changes in AVTR holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by AVTR's directors and management

Net Shares Purchased by Insiders−200k−100k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

AVTR Estimated quarterly lobbying spending

Source: U.S. Senate LDA

AVTR Revenue by Segment or Geography

AVTR's latest filing doesn't break out revenue by segment.

As of: Q3 2026 (Sep 30, 2026) · Source: SEC EDGAR (10-Q)

U.S. Patents

New AVTR patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to AVTR from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in AVTR

IJHiShares Core S&P Mid-Cap ETF$368.52M
VTIVanguard Morningstar Total Stock Market ETF$271.92M
VBVanguard Morningstar Small-Cap ETF$243.37M
DFSVU.S. Small Cap Value Portfolio ETF Class Shares$161.12M
VBRVanguard Morningstar Small-Cap Value ETF$158.20M
VXFVanguard Extended Market ETF$123.13M

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from AVTR’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
60% of score
54.88
Analyst Ratings
40% of score
56
News & Sentiment
No data yet
—

Recent Insider Activity

Buys
3
Sells
0
Buy Value
$1.29M
Distinct Buyers
3

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

ADPVAdaptiv Select ETF4.17%
PINKSimplify Health Care ETF3.84%
EPSBHarbor SMID Cap Core ETF (EPSB)2.08%
LSEQHarbor Long-Short Equity ETF (LSEQ)1.47%
XHYHBondBloxx USD High Yield Bond Healthcare Sector ETF1.22%
TSNFTruth Social American Next Frontiers ETF1.19%
HXEMast HedgeIndex Adaptive Equities ETF1.04%
NIXTResearch Affiliates Deletions ETF0.83%
NUSCNuveen ESG Small-Cap ETF0.80%
JHMHJohn Hancock Multifactor Health Care ETF0.64%
IVOVVanguard S&P Mid-Cap 400 Value ETF0.63%
SYGSPDR MFS Systematic Growth Equity ETF0.61%

Weight is the stock’s share of each fund’s holdings.